Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFlt1
Zygmunt, Tomasz, Gay, Carl Michael, Blondelle, Jordan, Singh, Manvendra K., Flaherty, Kathleen McCrone, Means, Paula Casey, Herwig, Lukas, Krudewig, Alice, Belting, Heinz-Georg, Affolter, Markus, Epstein, Jonathan A., Torres-Vázquez, Jesús
Published in Developmental cell (16.08.2011)
Published in Developmental cell (16.08.2011)
Get full text
Journal Article
A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers
Zhang, Bingnan, Ramkumar, Kavya, Cardnell, Robert John, Gay, Carl Michael, Stewart, C. Allison, Wang, Wei-Lien, Fujimoto, Junya, Wistuba, Ignacio I., Byers, Lauren Averett
Published in British journal of cancer (09.11.2021)
Published in British journal of cancer (09.11.2021)
Get full text
Journal Article
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
Della Corte, Carminia Maria, Ciaramella, Vincenza, Ramkumar, Kavya, Vicidomini, Giovanni, Fiorelli, Alfonso, Nardone, Valerio, Cappabianca, Salvatore, Cozzolino, Immacolata, Zito Marino, Federica, Di Guida, Gaetano, Wang, Qi, Cardnell, Robert, Gay, Carl Michael, Ciardiello, Davide, Martinelli, Erika, Troiani, Teresa, Martini, Giulia, Napolitano, Stefania, Wang, Jing, Byers, Lauren Averett, Ciardiello, Fortunato, Morgillo, Floriana
Published in Journal of translational medicine (22.11.2022)
Published in Journal of translational medicine (22.11.2022)
Get full text
Journal Article
Multidimensional analysis of B7 homolog 3 (B7-H3) RNA expression in small-cell lung cancer (SCLC) molecular subtypes
Gay, Carl Michael, Owonikoko, Taofeek K., Byers, Lauren Averett, Choudhury, Noura J., Ahmed, Sajid, Cain, Zachary, Qian, Xiaozhong, Brentnall, Matthew, Heeke, Simon, Poi, Ming, Wu, Sharon, Rudin, Charles M.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
SWOG S2012: Randomized phase II/III trial of first line platinum (P)/etoposide (E) with or without atezolizumab (NSC #783608) in patients with advanced or metastatic poorly differentiated extrapulmonary neuroendocrine carcinomas (NEC)
Zhen, David Bing, Moseley, Anna, Chiorean, E. Gabriela, Burgess, Earle F, Swisher, Elizabeth M., Gay, Carl Michael, Byers, Lauren Averett, Wistuba, Ignacio Ivan, Mahdi, Haider, Starr, Jason S., Othus, Megan, Chae, Young Kwang, Kurzrock, Razelle
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A phase I-III platform study evaluating the safety and efficacy of multiple therapies in patients with biomarker-defined locally advanced, unresectable stage III non–small-cell lung cancer (NSCLC)
Paz-Ares, Luis G., Gay, Carl Michael, Zhou, Caicun, Kato, Terufumi, Corrales, Luis, Redhead, Karl, Rahman, Ahmadur, Bradley, Denise, Theogaraj, Elizabeth, Hutchinson, Katherine E., Shagan, Sarah M., Solomon, Benjamin J.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Clinical outcomes of chemotherapy rechallenge in patients with metastatic non-small cell lung (NSCLC) who progressed on immunotherapy maintenance after front line platinum doublets and immunotherapy
Wang, Kaiwen, Fossella, Frank V., Negrao, Marcelo Vailati, Cascone, Tina, Gay, Carl Michael, Le, Xiuning, Vokes, Natalie I, Bueno Hume, Celyne, Hassan, Amy Aida, Gibbons, Don Lynn, Lee, J. Jack, Heymach, John, Zhang, Jianjun
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Driver mutations to predict for poorer outcomes in non-small cell lung cancer patients treated with concurrent chemoradiation and consolidation durvalumab
Liu, Yufei, Zhang, Zhe, Rinsurongkawong, Waree, Le, Xiuning, Gay, Carl Michael, Ning, Matthew S., Heymach, John, Zhang, Jianjun, Lin, Steven H.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Results of a phase 1b study of osimertinib plus sapanisertib or alisertib for osimertinib-resistant, EGFR-mutant non–small cell lung cancer (NSCLC)
Elamin, Yasir Y, Negrao, Marcelo Vailati, Fossella, Frank V., Byers, Lauren Averett, Zhang, Jianjun, Gay, Carl Michael, Tu, Janet Chen, Pozadzides, Jenny Vu, Tran, Hai T., Lu, Charles, Feng, Lei, Spelman, Amy R., Blumenschein, George R., Tsao, Anne S., Heymach, John
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
SWOG S2012: Randomized phase II/III trial of first line platinum/etoposide (P/E) with or without atezolizumab (NSC#783608) in patients (pts) with poorly differentiated extrapulmonary small cell neuroendocrine carcinomas (NEC)
Zhen, David Bing, Mayerson, Edward, Chiorean, E. Gabriela, Burgess, Earle F, Swisher, Elizabeth M., Gay, Carl Michael, Byers, Lauren Averett, Wistuba, Ignacio Ivan, Mahdi, Haider, Das, Satya, Starr, Jason S., Othus, Megan, Chae, Young Kwang, Kurzrock, Razelle
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Longitudinal tracking of ALK -positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial
Heeke, Simon, Gandhi, Saumil, Tran, Hai T., Lam, Vincent K., Byers, Lauren Averett, Gibbons, Don Lynn, Gay, Carl Michael, Altan, Mehmet, Antonoff, Mara, Le, Xiuning, Tu, Janet Chen, Pek, Michelle, Poh, Jonathan, Ngeow, Kao Chin, Tsao, Anne S., Cascone, Tina, Negrao, Marcelo Vailati, Blumenschein, George R., Heymach, John, Elamin, Yasir Y
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Analysis of tumor- and circulating-free DNA methylation to identify clinically relevant small cell lung cancer subtypes
Heeke, Simon, Gay, Carl Michael, Estecio, Marcos Roberto, Tran, Hai T., Morris, Benjamin B., Zhang, Bingnan, Tang, XiMing, Raso, Maria G, Rocha, Pedro, Arriola, Edurne, Hofman, Paul, Kopparapu, Prasad, Lovly, Christine M., Concannon, Kyle, Xi, Yuanxin, Diao, Lixia, Wang, Qi, Wang, Jing, Byers, Lauren Averett, Heymach, John
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC)
Abdel Karim, Nagla Fawzy, Miao, Jieling, Reckamp, Karen L., Gay, Carl Michael, Byers, Lauren Averett, Zhao, Yingqi, Redman, Mary Weber, Carrizosa, Daniel R., Wang, Wei-Lien, Petty, William J., Mehta, Kathan, Faller, Bryan A., Agamah, Edem S., Kasbari, Samer S., Malisetti, Rajini Katipamula, Kumar, Atul, Schallenkamp, John, Alluri, Krishna Chaitanya, Gray, Jhanelle Elaine, Kelly, Karen
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Clinical outcome and potential benefits of post-progression immunotherapy for patients with metastatic NSCLC with primary resistance to ipilumumab and nivolumab in the LONESTAR phase III study
Altan, Mehmet, Sui, Dawen, Gandhi, Saumil, Swisher, Stephen, Vokes, Natalie I, Antonoff, Mara, Zhang, Jianjun, Blumenschein, George R., Cascone, Tina, Elamin, Yasir Y, Gay, Carl Michael, Gibbons, Don Lynn, Le, Xiuning, Negrao, Marcelo Vailati, Skoulidis, Ferdinandos, Tsao, Anne S., Tu, Janet Chen, Spelman, Amy R., Lee, J. Jack, Heymach, John
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Abstract 3854: TNIK inhibition as a novel therapeutic in cMyc high/TTF1 low SCLC
Tanimoto, Azusa, Cardnell, Robert J., Morris, Benjamin B., Ramkumar, Kavya, Li, Shen, Wang, Qi, Stewart, Allison C., Gay, Carl Michael, Wang, Jing, Averett Byers, Lauren
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 1722: Subtype classification of small cell lung cancer (SCLC) tissues using the EpiCheck methylation sensitive restriction-based PCR platform
Savin, Orna, Netanely, Dvir, Heeke, Simon, Gay, Carl Michael, Estecio, Marcos Roberto, Danan, Shacade, Zaouch, Sarah, Shuali, Aharona, Ehrich, Mathias, Byers, Lauren Averett, Heymach, John Victor, Wasserstrom, Adam, Frumkin, Danny
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer
Della Corte, Carminia Maria, Gay, Carl Michael, Byers, Lauren Averett, Morgillo, Floriana
Published in EBioMedicine (01.01.2019)
Published in EBioMedicine (01.01.2019)
Get full text
Journal Article
Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFIt1
ZYGMUNT, Tomasz, GAY, Carl Michael, EPSTEIN, Jonathan A, TORRES-VAZQUEZ, Jesus, BLONDELLE, Jordan, SINGH, Manvendra K, MCCRONE FLAHERTY, Kathleen, CASEY MEANS, Paula, HERWIG, Lukas, KRUDEWIG, Alice, BELTING, Heinz-Georg, AFFOLTER, Markus
Published in Developmental cell (2011)
Get full text
Published in Developmental cell (2011)
Journal Article